PhotonPharma Inc., a biopharmaceutical company pioneering personalized cancer immunotherapies, today announced that patient recruitment has opened for its Phase 1 clinical trial evaluating Innocell™ ...
PhotonPharma Inc., a biopharmaceutical company pioneering personalized cancer immunotherapies, today announced that patient recruitment has opened for its Phase 1 clinical trial evaluating Innocelltm ...
Strategic Restructuring Eliminates Expenses Not Essential to the Phase 3 StudyKhursheed Anwer, Ph.D., Executive Vice President and Chief ...
A novel immune checkpoint vaccine induced antigen-specific food allergy tolerance in mice, preventing anaphylaxis. Learn more.
Griffith University researchers are on the cusp of a new vaccine to prevent chikungunya, a global health threat which attacks ...
A research team from POSTECH and ImmunoBiome in Korea, led by Professor Sin-Hyeog Im, has uncovered a new mechanism showing ...
News Medical on MSN
EBV-linked killer T cells implicated in multiple sclerosis
Researchers at UC San Francisco have uncovered a new clue to how Epstein-Barr virus (EBV) could contribute to multiple ...
Our immune system implements an array of strategies to combat threatening infections. White blood cells called cytotoxic T ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results